Paediatric sunburn: the experience of an Australian paediatric burns unit

Latifa Mah1, Paul Di Giovine, Linda Quinn

  • 1Burns Service, Women's and Children's Hospital, North Adelaide, South Australia, Australia. latifa.mah@health.wa.gov.au

Insights

Severe sunburn in children remains a significant issue, with hospital admissions occurring despite public awareness campaigns. This study identified specific patterns and factors contributing to pediatric sunburn cases, highlighting the need for targeted prevention strategies.

Area of Science:

  • Pediatric dermatology
  • Public health
  • Epidemiology

Background:

  • Hospital admissions for sunburn persist despite public health efforts.
  • Limited research exists on pediatric sunburn requiring hospitalization.
  • Understanding causative factors is crucial for effective prevention.

Purpose of the Study:

  • To provide a snapshot of pediatric sunburn hospital presentations.
  • To identify patterns and causative factors of severe sunburn in children.
  • To inform targeted public health interventions for sunburn prevention.

Main Methods:

  • Retrospective analysis of case records from a specialized Burns Service database.
  • Inclusion of pediatric patients presenting with sunburn between October 2006 and March 2011.
  • Data collection from the Women's and Children's Hospital in South Australia.

Main Results:

  • Eighty-one cases of pediatric sunburn requiring hospital presentation were identified.
  • Common factors included outdoor activities and high ultraviolet (UV) radiation exposure.
  • Sunburn patterns, location, and sun protection use varied by age and gender.

Conclusions:

  • Further large-scale studies are needed to identify at-risk pediatric populations.
  • Future educational programs should target specific subgroups and behaviors.
  • Tailored prevention campaigns can reduce hospital admissions for severe sunburn.
Abstract

Related Concept Videos

Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...